Description

Join OCHN, OCHCH, and Patients Choice Laboratories as we discuss how molecular testing can improve patient outcomes.

Using molecular testing in the home health setting revolutionizes how clinicians diagnose and manage infections. With rapid and precise results within 24 hours, providers can initiate appropriate treatment interventions quicker and more accurately. This in turn helps avoid unnecessary hospitalizations and helps stem the rise of antibiotic resistance with the detection of antimicrobial resistant genes.

We will also briefly discuss Pharmacogenetics (PGx) testing and how studies have shown it can increase treatment success, lower healthcare costs and hospitalization, and reduce trial-and-error medications.

Join us as we discuss how these outcomes might be possible for your health system and patients.

Our Speakers

Brad Moss, MBA, President, Patients Choice Laboratories

Thomas Payne, Chief Operations Officer, Patients Choice Laboratories

Jerome Nypaver, MA, BMLO, CG (ASCP), Director of Laboratory Operations, Patients Choice Laboratories

Presentation Overview

Molecular Testing

• What is molecular PCR testing?
• Molecular testing benefits for Home Health
• The real-world impact
• Available molecular services & tests

Pharmacogenetics (PGx)

• What is PGx?
• Cost Savings Studies & Stats
• Improved Outcome Study & Stats
• Z-code & reimbursement

Time for Q&A

About PCL

At PCL we are pioneering new ways to provide patient care. By delivering physicians with the most precise testing and industry leading robust reporting, patients and providers now have a real choice for diagnostic services. We specialize in toxicology and molecular diagnostics that provide precise and specific results allowing for quick diagnoses and treatment of patients. We provide expert testing in the areas of Toxicology, Infectious Disease and Pharmacogenetics. Learn more at pclabsdx.com